Linezolid compared with vancomycin for the prevention of methicillin-resistant Staphylococcus aureus or

Suzan Sacar1, Mustafa Sacar2, Ilknur Kaleli3

  • 1Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Pamukkale University, Denizli, Turkey.

Abstract

Insights

Linezolid and vancomycin effectively prevent vascular graft infections in rats. Both antibiotics showed similar efficacy in reducing bacterial counts, offering comparable protection against Staphylococcus infections.

Area of Science:

  • Surgical Infection Prevention
  • Antibiotic Prophylaxis
  • Vascular Surgery Complications

Background:

  • Vascular graft infections pose significant risks, including amputation and mortality.
  • Staphylococci are the primary pathogens responsible for these infections.

Purpose of the Study:

  • To evaluate the prophylactic effectiveness of linezolid versus vancomycin.
  • To prevent prosthetic vascular graft infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).

Main Methods:

  • A randomized, controlled experimental study was conducted in Wistar rats.
  • Rats received Dacron grafts and were divided into groups receiving no prophylaxis, vancomycin, or linezolid before inoculation with MRSA or MRSE.
  • Graft cultures were assessed after 7 days to quantify bacterial growth.

Main Results:

  • Both vancomycin and linezolid significantly inhibited bacterial growth compared to untreated controls (P < 0.001).
  • No significant difference in bacterial counts was found between the vancomycin and linezolid prophylaxis groups.
  • MRSA demonstrated a higher affinity for Dacron prostheses than MRSE.

Conclusions:

  • Linezolid is as effective as vancomycin in suppressing bacterial colony counts in infected vascular grafts.
  • Both antibiotics provide comparable prophylactic benefits against MRSA and MRSE in this rat model.